Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Kekkaku : [Tuberculosis]
|
June 21, 2002
[Thymoma complicated with miliary tuberculosis]
Akira Kisohara, Noriaki Takahashi, Yoshiaki Koya, et al.
Thoracic Cancer
|
May 25, 2024
Schwannoma diagnosed by endobronchial ultrasound-guided intranodal forceps biopsy using standard-sized biopsy forceps: A case report
Keigo Uchimura, Teruaki Ishida, Shumei Kan, et al.
Japanese Journal of Clinical Oncology
|
August 12, 2020
Evaluation of histological specimens obtained by two types of EBUS-TBNA needles: a comparative study
Keigo Uchimura, Kei Yamasaki, Shinji Sasada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 27, 2005
[Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients]
Tetsuo Shimizu, Noriaki Takahashi, Masahiro Terakado, et al.
Cancer Diagnosis & Prognosis
|
May 5, 2025
Prognostic Factors in EGFR Mutation-positive Patients With Bone Metastases from Lung Adenocarcinoma
Shunzo Osaka, Junzo Kawashima, Ryoma Kaguchi, et al.
The Lancet. Respiratory Medicine
|
October 1, 2025
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial
Tetsuhiko Asao, Yu Saida, Satoshi Watanabe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 7, 2023
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)
Satoshi Watanabe, Naoki Furuya, Atsushi Nakamura, et al.
Cancer Science
|
April 21, 2026
Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2
Yasushi Goto, Makoto Nishio, Kadoaki Ohashi, et al.
Cancer Science
|
December 11, 2025
Atezolizumab + Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2)
Hiroshige Yoshioka, Makoto Nishio, Kadoaki Ohashi, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
October 1, 2024
Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A
Keita Miura, Takehito Shukuya, Naoki Furuya, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Kekkaku : [Tuberculosis]
|
June 21, 2002
[Thymoma complicated with miliary tuberculosis]
Akira Kisohara, Noriaki Takahashi, Yoshiaki Koya, et al.
Thoracic Cancer
|
May 25, 2024
Schwannoma diagnosed by endobronchial ultrasound-guided intranodal forceps biopsy using standard-sized biopsy forceps: A case report
Keigo Uchimura, Teruaki Ishida, Shumei Kan, et al.
Japanese Journal of Clinical Oncology
|
August 12, 2020
Evaluation of histological specimens obtained by two types of EBUS-TBNA needles: a comparative study
Keigo Uchimura, Kei Yamasaki, Shinji Sasada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 27, 2005
[Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients]
Tetsuo Shimizu, Noriaki Takahashi, Masahiro Terakado, et al.
Cancer Diagnosis & Prognosis
|
May 5, 2025
Prognostic Factors in EGFR Mutation-positive Patients With Bone Metastases from Lung Adenocarcinoma
Shunzo Osaka, Junzo Kawashima, Ryoma Kaguchi, et al.
The Lancet. Respiratory Medicine
|
October 1, 2025
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial
Tetsuhiko Asao, Yu Saida, Satoshi Watanabe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 7, 2023
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)
Satoshi Watanabe, Naoki Furuya, Atsushi Nakamura, et al.
Cancer Science
|
April 21, 2026
Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2
Yasushi Goto, Makoto Nishio, Kadoaki Ohashi, et al.
Cancer Science
|
December 11, 2025
Atezolizumab + Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2)
Hiroshige Yoshioka, Makoto Nishio, Kadoaki Ohashi, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
October 1, 2024
Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A
Keita Miura, Takehito Shukuya, Naoki Furuya, et al.
Page
of 2